USD 32.79
Price
0.31
(0.95%)
Day Change
|
|
---|
HRMY, the overall quality is not good (Quality = 46) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
In details, quality factors are not quite good , financial health is not good , and ability to make profit is good , ...
Quality Factors |
|
50% |
Timing Factors |
|
28% |
Financial Health |
|
45% |
Ability to Make Profit |
|
72% |
Return to Investors |
|
37% |
Registration Details |
Analyze Date | 2024-11-21 20:04:42 |
Symbol | HRMY |
Name | HARMONY BIOSCIENCES HOLDINGS |
Sector | Healthcare >> Biotechnology |
Market | NASDAQ |
Listed Shares | 57.03 M |
Par Value | N/A |
Calculated From | Quarter |
Sign | N/A |
Market Cap (M.USD) / Sector Average | 1,852.38 / 3,489.12 |
News, Concensus, ... |
Estimation Consensus | See at WSJ.com |
Full details | See at WSJ.com |
Chart | See in Chart feature |
News | See at Yahoo Finance |